Qlucore Insights Can Classify Primary Lung Samples, Metastatic Lesions
Qlucore has released a new version of Qlucore Insights tailored for lung cancer, capable of classifying both primary and metastatic lesions.
Read MorePosted by Chris Wolski | May 23, 2024 | Cancer |
Qlucore has released a new version of Qlucore Insights tailored for lung cancer, capable of classifying both primary and metastatic lesions.
Read MorePosted by Andy Lundin | Apr 4, 2024 | Breast |
This collaborative study seeks to represent a significant step forward in digital pathology and oncology breast cancer research
Read MorePosted by Andy Lundin | Mar 25, 2024 | Unknown Origin & Other Cancer Types |
The tumor cell enumeration assay is a diagnostic test that is promising for establishing the diagnosis of leptomeningeal metastases.
Read MorePosted by Andy Lundin | Feb 16, 2024 | Cancer |
By analyzing fragments of cfDNA in a simple blood draw, the Galleri test can screen for many deadly cancers.
Read MorePosted by Andy Lundin | Jan 25, 2024 | Digital Pathology |
New research has led to the U.K. government approving the use of digital pathology to help speed up the analysis of cancer screening samples.
Read More